Zanubrutinib

BRUKINSA

Kinase Inhibitor

NADAC/unit N/A

No Shortage Tier 1: 17.9% PA Req: 99.4%

Zanubrutinib targets specific kinase enzymes involved in cancer cell growth and proliferation.

Covered Lives

Generic Manufacturers

BEONE MEDICINES USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Zanubrutinib drfinder.aiFind doctors who prescribe Zanubrutinib rxpbm.aiPBM spread analysis for Zanubrutinib clinicalrx.aiClinical profile: Zanubrutinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.